NMN · 5-Amino-1MQ · NAD+
- Amino Pure Canada
- May 2
- 13 min read
Comprehensive Research Summary
Molecular Profile · Description · Key Research Benefits · Scientific References
Amino Pure Canada | May 2026
For Research & Laboratory Use Only | Not for Human Consumption
How These Three Compounds Are Connected
NMN, 5-Amino-1MQ, and NAD+ are not independent molecules - they are part of the same biological pathway. Understanding each one requires understanding how they interact:
NAD+ is the master coenzyme your cells use for energy, DNA repair, and aging control. It declines sharply with age. NMN is the most direct precursor your body uses to manufacture NAD+. More NMN = more NAD+. 5-Amino-1MQ is an NNMT inhibitor. NNMT is an enzyme that consumes nicotinamide - the raw material your body needs to make NMN and NAD+. Blocking NNMT preserves more of that raw material, pushing more NAD+ production. Together these three compounds target the same NAD+ pathway from three different angles, making them highly relevant for multi-mechanism aging and metabolic research. |
Section 1 - NMN (Nicotinamide Mononucleotide) |
1.1 Molecular Profile
Full Name | Nicotinamide Mononucleotide (Beta-NMN) |
Chemical Formula | C₁₁H₁₅N₂O₈P |
Molecular Weight | 334.22 g/mol |
CAS Number | 1094-61-7 |
Physical Form | White to off-white crystalline powder |
Solubility | Highly soluble in water (up to 50 mg/mL) |
Storage | Short-term: 2–8°C | Long-term: -20°C, protected from light |
pH (100mg/mL) | 3.0 – 4.0 |
Also Known As | β-NMN, β-Nicotinamide Mononucleotide, Nicotinamide Ribotide, NMN |
1.2 What Is NMN?
NMN is a naturally occurring bioactive nucleotide found in small quantities in foods such as edamame, broccoli, avocado, cabbage, and cucumber. It is composed of three parts: a nicotinamide base (a form of vitamin B3), a ribose sugar, and a phosphate group.
Its primary biological role is as the most direct precursor to NAD+ in the body's main biosynthesis pathway. When NMN enters a cell via its transporter protein (Slc12a8, discovered by Imai et al. at Washington University), the enzyme NMNAT converts it to NAD+ almost immediately - making it the most efficient NAD+ booster identified to date.
By middle age, NAD+ levels in human tissues have fallen to approximately half of youthful levels. Because NMN is the direct building block for NAD+, supplementing with NMN is the most studied strategy to restore this decline.
1.3 Key Research Benefits (Plain Language)
Energy & Metabolism
• NMN restores NAD+ levels in muscle, liver, fat tissue, and the brain - all tissues where energy production depends on adequate NAD+
• Animal studies show NMN suppresses age-related weight gain, enhances energy metabolism, and improves physical endurance without changes in food intake
• Human trials confirm oral NMN is rapidly absorbed and effectively raises blood NAD+ levels within hours
Insulin Sensitivity & Metabolic Health
• Washington University clinical trials found NMN improved insulin sensitivity in postmenopausal women with prediabetes - a significant human finding
• NMN restores gene expression related to oxidative stress and inflammatory response through SIRT1 activation
• Animal studies show NMN ameliorates glucose intolerance by restoring hepatic insulin sensitivity
Brain & Neurological Health
• Dr. Shin-ichiro Imai's lab at Washington University demonstrated in 2023 that NMN supplementation restores declining NAD+ levels in four regions of the aging hypothalamus
• NAD+ depletion in the hippocampus is linked to cognitive decline; NMN replenishment shows protective effects in animal models
• Research suggests potential neuroprotective effects relevant to neurodegenerative disease models
DNA Repair & Cellular Protection
• NAD+ is essential for PARP enzymes that repair broken DNA strands. NMN replenishment directly supports this repair mechanism
• NMN activates sirtuins (SIRT1–7) - a family of proteins responsible for DNA maintenance, inflammation control, and cellular stress resistance
• Animal studies show NMN reduces oxidative stress markers and DNA damage accumulation associated with aging
Cardiovascular Health
• A 2024 review published in the International Journal of Molecular Sciences (Dalian Medical University) found NMN alleviates the development of cardiovascular conditions including heart failure, atherosclerosis, and myocardial ischemia/reperfusion injury
• NAD+ is critical for mitochondrial function in cardiac tissue - NMN supplementation has shown protective effects in ischemia models
Anti-Aging & Longevity
• The NAD World 3.0 framework proposed by Imai positions NMN as a systemic signaling molecule central to aging control
• A 2024 human trial found 300mg/day NMN nearly doubled telomere length in blood cells within 90 days in men aged 40–60 - a direct molecular marker of anti-aging effect
• Human trials report improvements in sleep quality, walking speed, muscle strength, skin aging, and hearing in older adults
1.4 Key Researchers
• Dr. Shin-ichiro Imai - Theodore & Bertha Bryan Distinguished Professor, Washington University School of Medicine. Lead architect of the NAD World framework and pioneer of NMN aging research. Over 35,000 scholarly citations.
• Dr. David Sinclair - Professor of Genetics, Harvard Medical School; Co-Director, Paul F. Glenn Center for Biology of Aging Research. Global authority on sirtuins, NAD+ metabolism, and longevity science. Personal NMN user at 1g/day.
• Dr. Charles Brenner - Alfred E. Mann Family Foundation Chair, City of Hope National Medical Center. Discoverer of NR as a NAD+ precursor; major contributor to understanding NAD+ metabolism in disease.
• Dr. Jun Yoshino - Washington University School of Medicine. Lead author on landmark NMN human clinical trial (insulin sensitivity in women with prediabetes).
Section 2 - 5-Amino-1MQ (NNMT Inhibitor) |
Classification Note: 5-Amino-1MQ is a small molecule compound - not a peptide. It is a quinolinium salt frequently grouped alongside peptides in research catalogs. It contains no amino acid chain. Researchers should note this distinction when designing studies or reporting results. |
2.1 Molecular Profile
Full Name | 5-Amino-1-Methylquinolinium (Iodide Salt) |
Chemical Class | Quinolinium salt - small molecule NNMT inhibitor |
Molecular Weight | 286.11 g/mol (salt form) | ~159.21 g/mol (cation only) |
Target Enzyme | NNMT (Nicotinamide N-Methyltransferase) |
Mechanism | NAD+ salvage pathway modulation via NNMT inhibition |
IC₅₀ | ≈1.2 μM (in vitro NNMT inhibition) |
Physical Form | Lyophilized crystal/powder |
Key Advantage | Membrane-permeable - crosses cell walls efficiently (earlier NNMT inhibitors could not) |
Purity Standard | ≥99% HPLC (research grade) |
Storage | Store at 2–8°C; protect from light; avoid freeze-thaw cycles |
2.2 What Is 5-Amino-1MQ?
5-Amino-1MQ (5-Amino-1-Methylquinolinium) is a synthetic small molecule developed through structure-activity relationship research at the University of Texas at Austin by Dr. Harsha Neelakantan and colleagues. Its sole function is to selectively block the enzyme NNMT (Nicotinamide N-Methyltransferase).
NNMT is an enzyme found primarily in the liver, white adipose tissue, kidney, brain, and skeletal muscle. It works by consuming nicotinamide (the raw material your body needs to make NAD+) and a methyl donor called SAM, converting them into 1-methylnicotinamide (1-MNA) and S-adenosylhomocysteine. In plain terms: NNMT acts as a brake on your body's ability to produce NAD+.
In obese and aging individuals, NNMT activity increases dramatically in fat tissue - meaning the brake is stuck on. 5-Amino-1MQ releases that brake. Unlike earlier NNMT inhibitors that worked in test tubes but could not enter living cells, 5-Amino-1MQ is specifically engineered to cross cell membranes efficiently, making it the primary research tool for NNMT inhibition studies.
2.3 Key Research Benefits
Fat Metabolism & Weight
• In diet-induced obese (DIO) mice, 5-Amino-1MQ produced approximately 7% body weight reduction in just 11 days
• Fat cell (adipocyte) size and white adipose tissue mass decreased significantly
• Critically: food intake did not change - the mechanism is purely metabolic (increased energy expenditure), not appetite suppression
• The foundational Kraus et al. (2014, Nature) study showed NNMT knockdown produced a 47% reduction in relative fat mass in animal models
NAD+ Restoration & Cellular Energy
• By blocking NNMT, 5-Amino-1MQ frees nicotinamide to re-enter the NAD+ salvage pathway - directly increasing intracellular NAD+ levels
• Higher NAD+ activates SIRT1 and other sirtuins - proteins linked to longevity, DNA repair, mitochondrial function, and inflammation control
• This makes 5-Amino-1MQ the only known compound that boosts NAD+ by targeting the consumption side of the pathway rather than the production side
Muscle Aging & Sarcopenia
• NNMT protein is approximately 3x more abundant in aged muscle tissue than in young muscle - directly linking it to age-related muscle decline
• The 2024 Dimet-Wiley et al. study (Scientific Reports) found NNMT inhibition produced ~40% greater grip strength in aged sedentary mice vs untreated controls
• Aged mice treated with 5-Amino-1MQ during exercise showed ~150% increase in daily running distance vs ~75% for exercise alone
• NNMT inhibition reactivated aged muscle stem cells (satellite cells) responsible for muscle repair - described as the first pharmacological approach to enhance aged muscle regeneration
Insulin Sensitivity
• NNMT is overexpressed in white adipose tissue of obese and diabetic animal models
• NNMT inhibition improved glucose clearance and GLUT4 expression (the transporter moving glucose into cells) in research models
• Emerging evidence suggests NNMT inhibition may increase PAHSA molecules, which have anti-diabetic and anti-inflammatory properties
Gut Microbiome
• A 2022 PubMed study found 5-Amino-1MQ combined with a low-fat diet produced distinct and favorable gut microbiome changes
• Diet switch alone could not restore normal metabolic markers; the combination with 5-Amino-1MQ did - suggesting the compound's effects extend beyond simple caloric mechanisms
2.4 Key Researchers
• Dr. Barbara B. Kahn - Harvard Medical School / Beth Israel Deaconess Medical Center. Led the foundational 2014 Nature study establishing NNMT as a validated therapeutic target in obesity and metabolic disease.
• Dr. Harsha Neelakantan - University of Texas at Austin. Lead developer of 5-Amino-1MQ. Published the defining 2017 Journal of Medicinal Chemistry paper demonstrating selective, membrane-permeable NNMT inhibition in living cells.
• Dr. Stanley Watowich - University of Texas Medical Branch. Co-investigator across multiple 5-Amino-1MQ studies including the 2024 sarcopenia findings.
• Dr. Christopher Fry & Andrea Dimet-Wiley - University of Texas. Lead authors of the landmark 2024 Scientific Reports study demonstrating NNMT inhibition improves aged muscle strength and endurance.
Section 3 - NAD+ (Nicotinamide Adenine Dinucleotide) |
3.1 Molecular Profile
Full Name | Nicotinamide Adenine Dinucleotide (Oxidized Form) |
Chemical Formula | C₂₁H₂₇N₇O₁₄P₂ |
Molecular Weight | 663.43 g/mol |
CAS Number | 53-84-9 |
Physical Form | White to off-white lyophilized powder |
Solubility | Highly soluble in water |
Storage | -20°C, protected from light and moisture |
Also Known As | NAD+, Coenzyme I, DPN (Diphosphopyridine Nucleotide) |
Structure | Two nucleotides joined by a pyrophosphate linkage: NMN + AMP |
Redox Partner | NAD+/NADH (oxidized/reduced pair); NADP+/NADPH for anabolic reactions |
Purity (Research) | Typically ≥98% HPLC |
3.2 What Is NAD+?
NAD+ (Nicotinamide Adenine Dinucleotide) is a coenzyme found in every living cell in the body. It was first discovered in 1906 by Sir Arthur Harden at the London School of Hygiene and Tropical Medicine, originally identified as a yeast fermentation cofactor. It is now understood to be one of the most fundamental molecules in all of biology.
Structurally, NAD+ consists of two nucleotides joined by a pyrophosphate bridge: one nucleotide contains nicotinamide (from NMN) and the other contains adenine (from AMP). It exists in two forms: the oxidized form (NAD+) and the reduced form (NADH). The ratio between these two forms regulates entire metabolic pathways.
NAD+ participates in over 500 enzymatic reactions across the body. Its two primary roles are: (1) as an electron carrier in energy metabolism (glycolysis, the TCA cycle, and oxidative phosphorylation), and (2) as a substrate consumed by critical signaling enzymes - sirtuins, PARPs, and CD38 - that govern DNA repair, gene expression, inflammation, and aging.
Critical aging fact: NAD+ levels in human tissues decline by approximately 50% between youth and middle age, and continue declining thereafter. This decline is now recognized by researchers at Washington University, Harvard, and the National Institute on Aging as a central driver of the aging process and the diseases associated with it. |
3.3 Key Research Benefits
Cellular Energy Production
• NAD+ is the essential electron carrier in glycolysis and the TCA (Krebs) cycle - it is how your cells convert food into usable energy (ATP)
• Without sufficient NAD+, mitochondria cannot produce energy efficiently - leading to cellular fatigue, metabolic dysfunction, and accelerated aging
• NAD+/NADH ratio is a direct measure of cellular energy status and metabolic health
DNA Repair
• PARP enzymes (poly ADP-ribose polymerases) are the primary DNA repair tools in the cell - they require NAD+ as their energy source
• When DNA damage is extensive (from aging, UV, toxins), PARPs activate strongly and rapidly deplete cellular NAD+, triggering a cascade of cell dysfunction
• Maintaining high NAD+ levels ensures PARPs can repair DNA damage without depleting the cellular energy reserve
Sirtuin Activation (The Longevity Enzymes)
• Sirtuins (SIRT1–7) are a family of NAD+-dependent proteins responsible for DNA maintenance, chromosome stability, inflammation control, metabolic regulation, and lifespan extension
• Sirtuins cannot function without NAD+ - they are literally switched off when NAD+ levels fall
• SIRT1 (nucleus/cytosol) controls metabolism and stress response. SIRT3 (mitochondria) regulates mitochondrial function. SIRT6 controls DNA repair. Each requires NAD+
• Research by Dr. David Sinclair has established that sirtuin activation is one of the most promising mechanisms for extending healthspan
Mitochondrial Health
• NAD+ is the master regulator of mitochondrial function. Declining NAD+ correlates directly with mitochondrial dysfunction in aging
• A 2025 review published in npj Metabolic Health and Disease (Nature) found declining NAD+ is associated with cognitive decline, sarcopenia, and metabolic diseases - all linked to mitochondrial deterioration
• Restoring NAD+ via precursors has been shown to reverse mitochondrial dysfunction in multiple tissue types
Immune Function & Inflammation
• CD38 is an enzyme that consumes NAD+ to support immune cell signaling - CD38 activity increases dramatically with aging, causing NAD+ depletion
• NAD+ levels directly regulate inflammatory cytokine production and the activity of immune cells
• Research from multiple institutions including St. Jude Children's Research Hospital links NAD+ depletion to impaired adaptive cellular stress responses and chronic inflammation
Metabolic & Endocrine Regulation
• NAD+ regulates glycolysis, fatty acid oxidation, the TCA cycle, and oxidative phosphorylation - essentially the entire spectrum of energy metabolism
• SIRT1 activation by NAD+ controls insulin sensitivity and glucose metabolism, making NAD+ central to Type 2 diabetes research
• NAD+ depletion is associated with age-related metabolic disorders including obesity, insulin resistance, and dyslipidemia
Neurological Health
• NAD+ levels in the brain decline with aging and are linked to neurodegeneration in models of Alzheimer's disease, Parkinson's disease, and ALS
• Research from Washington University shows NAD+ decline in the hypothalamus is connected to disrupted circadian rhythms and age-related sleep changes
• Restoring NAD+ in brain tissue has shown neuroprotective effects across multiple preclinical models
3.4 Key Researchers
• Dr. Shin-ichiro Imai - Washington University School of Medicine. Co-author on foundational NAD+ biosynthesis and NMN/NAD+ aging pathway research published across Nature, Cell Metabolism, and npj Aging.
• Dr. David Sinclair - Harvard Medical School. Global authority on NAD+, sirtuins, and longevity. Author of the New York Times bestseller Lifespan: Why We Age – And Why We Don’t Have To.
• Dr. Charles Brenner - City of Hope National Medical Center. Discoverer of NR as NAD+ precursor; key contributor to understanding NAD+ salvage and biosynthesis pathways.
• Dr. Johan Auwerx - EPFL (Ecole Polytechnique Fédérale de Lausanne). Major NAD+ aging researcher; work on NAD+ precursors restoring mitochondrial function published in Science, Cell Metabolism, and Nature.
• Sean Johnson & Shin-ichiro Imai - Washington University. Authors of the landmark F1000Research 2018 review establishing NAD+ biosynthesis as a therapeutic target for age-related disease.
Scientific References |
All references below are peer-reviewed publications from reputable universities, medical schools, and journals. They are organized by compound and topic.
NMN References
1. Mills KF, Yoshida S, Stein LR, Imai S et al. (2016). "Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice." Cell Metabolism, Vol. 24, pp. 795–806 | Washington University School of Medicine. https://pubmed.ncbi.nlm.nih.gov/28068222/
2. Yoshino J et al. (Washington University School of Medicine) (2021). "Nicotinamide Mononucleotide Increases Muscle Insulin Sensitivity in Prediabetic Women." Science, Vol. 372, pp. 1224–1229. https://pubmed.ncbi.nlm.nih.gov/34108263/
3. Lin Yi, Maier AB, Tao R, Imai S et al. (2023). "The efficacy and safety of β-NMN supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled clinical trial." GeroScience, Vol. 45, pp. 29–43. https://pubmed.ncbi.nlm.nih.gov/36482258/
4. Grozio A, Mills KF, Yoshino J, Imai S et al. (2019). "Slc12a8 is a nicotinamide mononucleotide transporter." Nature Metabolism, Vol. 1, pp. 47–57 | Washington University School of Medicine. https://medicine.washu.edu/news/scientists-identify-new-fuel-delivery-route-for-cells/
5. Unno J, Mills KF, Imai S et al. (2024). "Absolute quantification of nicotinamide mononucleotide in biological samples (dimeLC-MS/MS)." npj Aging, Springer Nature | Washington University School of Medicine. https://www.ssi.shimadzu.com/news/2024-02-13-innovative-technology-health-developed-shimadzu-washington-university-life-expectancy.html
6. Deng H, Ding D, Ma Y et al. (Dalian Medical University) (2024). "Nicotinamide Mononucleotide: Research Process in Cardiovascular Diseases." International Journal of Molecular Sciences, Vol. 25, 9526. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11394709/
7. Song J et al. (2023). "NMN supplementation is safe and confers benefits to physical function, insulin sensitivity, and telomere length." Advances in Nutrition | PubMed Review. https://www.nmn.com/news/exploring-recent-nmn-human-trial-advancements
8. Nadeeshani H et al. (2022). "The Safety and Antiaging Effects of Nicotinamide Mononucleotide in Human Clinical Trials: an Update." PMC Review, National Center for Biotechnology Information (NCBI). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10721522/
9. Imai S (Washington University) (2023). "NAD World 3.0: the importance of the NMN transporter and eNAMPT for the aging brain." npj Aging, Springer Nature. https://www.nmn.com/news/new-nad-world-3-0-theory-emphasizes-nmns-importance-in-aging
10. Irie J, Inagaki E, Fujita M, Imai S et al. (2020). "Oral Administration of Nicotinamide Mononucleotide Is Safe and Efficiently Increases Blood NAD+ Levels in Healthy Subjects." Endocrine Journal | PMC9036060. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036060/
5-Amino-1MQ References
11. Kraus D, Yang Q, Kong D, Banks AS, Zhang L, Kahn BB et al. (Harvard Medical School) (2014). "Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity." Nature, Vol. 508, pp. 258–262. https://pubmed.ncbi.nlm.nih.gov/24717514/
12. Neelakantan H, Vance V, McHardy SF, Watowich SJ et al. (University of Texas) (2017). "Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice." Journal of Medicinal Chemistry | Biochemical Pharmacology. https://pmc.ncbi.nlm.nih.gov/articles/PMC5826726/
13. Neelakantan H, Brightwell CR, Graber TG, Watowich SJ et al. (University of Texas) (2019). "Small molecule nicotinamide N-methyltransferase inhibitor activates senescent muscle stem cells and improves regenerative capacity of aged skeletal muscle." Biochemical Pharmacology, Vol. 163, pp. 481–492. https://pubmed.ncbi.nlm.nih.gov/30753815/
14. Dimet-Wiley AL, Latham CM, Brightwell CR, Neelakantan H, Fry CS, Watowich SJ et al. (2024). "Nicotinamide N-methyltransferase inhibition mimics and boosts exercise-mediated improvements in muscle function in aged mice." Scientific Reports, Vol. 14, Article 15554. https://www.nature.com/articles/s41598-024-66034-9
15. Eckert MA et al. (2019). "Proteomics reveals NNMT as a master metabolic regulator of cancer associated fibroblasts." PMC Article - ovarian cancer/CAF tumor burden study. https://pmc.ncbi.nlm.nih.gov/articles/PMC6690743/
16. Various authors. (2022). "Reduced calorie diet combined with NNMT inhibition establishes a distinct microbiome in DIO mice." PubMed PMID: 35013352. https://pubmed.ncbi.nlm.nih.gov/35013352/
17. Various authors. (2021). "Roles of Nicotinamide N-Methyltransferase in Obesity and Type 2 Diabetes." PMC Review Article PMC8337113. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8337113/
NAD+ References
18. Verdin E (Gladstone Institutes / UCSF) (2015). "NAD+ in aging, metabolism, and neurodegeneration." Science, Vol. 350, pp. 1208–1213. https://pubmed.ncbi.nlm.nih.gov/26785480/
19. Rajman L, Chwalek K, Sinclair DA (Harvard Medical School) (2018). "Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence." Cell Metabolism, Vol. 27, pp. 529–547. https://pubmed.ncbi.nlm.nih.gov/29514064/
20. Johnson S, Imai S (Washington University School of Medicine) (2018). "NAD+ biosynthesis, aging, and disease." F1000Research, Vol. 7, pp. 132. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5795269/
21. Covarrubias AJ, Perrone R, Grozio A, Verdin E (2021). "NAD+ metabolism and its roles in cellular processes during ageing." Nature Reviews Molecular Cell Biology, Vol. 22, pp. 119–141. https://pubmed.ncbi.nlm.nih.gov/33353981/
22. Chini CCS, Zeidler JD, Kashyap S et al. (Mayo Clinic / St. Jude’s) (2021). "Role of NAD+ in regulating cellular and metabolic signaling pathways." Molecular Metabolism, PMC7973386. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973386/
23. Mehmel M, Jovanovic N, Spitz U (2020). "Nicotinamide Riboside - the current state of research and therapeutic uses." Nutrients, PMC7238909 (covers NAD+ pathway comprehensively). https://pmc.ncbi.nlm.nih.gov/articles/PMC7238909/
24. Fang M et al. (2023). "Nicotinamide Adenine Dinucleotide in Aging Biology: Potential Applications and Many Unknowns." eLife / PubMed PMID: 37364580. https://pubmed.ncbi.nlm.nih.gov/37364580/
25. Remie CME et al. (npj Metabolic Health and Disease) (2025). "The role of NAD+ metabolism and its modulation of mitochondria in aging and disease." npj Metabolic Health and Disease, Nature Publishing Group. https://www.nature.com/articles/s44324-025-00067-0
26. Katsyuba E, Romani M, Auwerx J et al. (EPFL) (2020). "The Central Role of the NAD+ Molecule in the Development of Aging and Prevention of Chronic Age-Related Diseases." International Journal of Molecular Sciences, PMC9917998. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917998/
For Research & Laboratory Use Only | Not Intended for Human Consumption
All findings cited are from peer-reviewed preclinical and clinical studies. Consult full source papers before designing research protocols.
Amino Pure Canada | aminopureca
Comments